Amiodarone 200 mg Tablet PCD Franchise in Mumbai

Antiarrhythmic Cardiac Medicine Supplier in Delhi

Cardiology Care Pharma Franchise in Chennai

High-Dose Amiodarone Tablet Distributor in Ahmedabad

Arrhythmia Management Medicine Stockist in Hyderabad
Amiodarone 200 mg Export & Manufacturing in Pune

Home/Products /amiodarone-hydrochloride-ip-200-mg-tablet

Amityle 200 Tablet

Composition : Amiodarone (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Amityle 200 Tablet contains Amiodarone 200 mg, a potent antiarrhythmic drug used to prevent and treat life-threatening heart rhythm disorders such as ventricular tachycardia, atrial fibrillation, and other supraventricular arrhythmias.

It works by modulating the cardiac electrical conduction system, helping restore a normal heartbeat and reduce the risk of sudden cardiac events. This high-dose formulation is essential for patients requiring long-term rhythm control therapy.

Belonging to the cardiology segment, Amityle 200 Tablet is widely prescribed in hospitals, cardiology clinics, and specialized care centers. Its clinical efficacy ensures high demand and repeat prescriptions across India.

For PCD pharma franchise partners, bulk distributors, exporters, and third-party manufacturing clients, Amityle 200 Tablet provides a profitable B2B opportunity. Its inclusion in a cardiac portfolio guarantees recurring demand and strong market presence.


Read More

About the Product

Amityle 200 Tablet contains Amiodarone 200 mg, a potent antiarrhythmic drug used to prevent and treat life-threatening heart rhythm disorders such as ventricular tachycardia, atrial fibrillation, and other supraventricular arrhythmias.

It works by modulating the cardiac electrical conduction system, helping restore a normal heartbeat and reduce the risk of sudden cardiac events. This high-dose formulation is essential for patients requiring long-term rhythm control therapy.

Belonging to the cardiology segment, Amityle 200 Tablet is widely prescribed in hospitals, cardiology clinics, and specialized care centers. Its clinical efficacy ensures high demand and repeat prescriptions across India.

For PCD pharma franchise partners, bulk distributors, exporters, and third-party manufacturing clients, Amityle 200 Tablet provides a profitable B2B opportunity. Its inclusion in a cardiac portfolio guarantees recurring demand and strong market presence.


Common side effects may include nausea, constipation, fatigue, dizziness, skin discoloration, and sensitivity to sunlight. Rare but serious side effects include thyroid disorders, lung toxicity, liver dysfunction, and severe heart rhythm disturbances. Seek medical attention if you experience shortness of breath, jaundice, or chest pain.

Amityle 200 Tablet is indicated for the treatment of ventricular arrhythmias, atrial fibrillation, and supraventricular tachycardia. It helps reduce palpitations, irregular heartbeats, and the risk of sudden cardiac events.

Take Amityle 200 Tablet exactly as prescribed. Do not stop or change the dose without consulting your doctor. Avoid alcohol and grapefruit juice while on therapy. Regular monitoring of liver, thyroid, lung, and heart function is recommended during long-term use.

Store in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation